M Jurima
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in
-
- Metabolism and Genetic Disorders 4
-
- Botanical Research and Chemistry 3
- Co-authors
- T. Inaba (9 shared papers)W. Kalow (8 shared papers)W Kalow (2 shared papers)D. Kadar (2 shared papers)Masayuki Nakano (1 shared paper)Bing Tang (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)Clinical Pharmacology & Therapeutics (2 papers)British Journal of Clinical Pharmacology (1 paper)Canadian Journal of Physiology and Pharmacology (1 paper)PubMed (1 paper)
- Partner nations
- Canada
In The Last Decade
M Jurima
9 papers receiving 375 citations
Peers
Comparison fields: 5 of 58
- Pharmacology 282
- Clinical Biochemistry 54
- Oncology 105
- Pediatrics, Perinatology and Child Health 61
- Biochemistry 23
Countries citing papers authored by M Jurima
This map shows the geographic impact of M Jurima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Jurima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Jurima more than expected).
Fields of papers citing papers by M Jurima
This network shows the impact of papers produced by M Jurima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Jurima. The network helps show where M Jurima may publish in the future.
Co-authors
The 6 scholars most cited alongside M Jurima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 166 | |
| 2 | 1985 | 101 | |
| 3 | 1984 | 38 | |
| 4 | Family studies of mephenytoin hydroxylation deficiency. | 1986 | 30 |
| 5 | 1985 | 19 | |
| 6 | 1984 | 17 | |
| 7 | 1985 | 16 | |
| 8 | 1985 | 8 | |
| 9 | 1984 | 1 | |
| 10 | GENETIC POLYMORPHISM OF MEPHENYTOIN P4 HYDROXYLATION: DIFFERENCES BETWEEN ORIENTALS AND CAUCASIANS | 1985 | 1 |
About M Jurima
M Jurima is a scholar working on Clinical Biochemistry, Ecology, Evolution, Behavior and Systematics, Cancer Research, Oncology and Pharmacology, having authored 10 papers that have together received 397 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (4 papers), Botanical Research and Chemistry (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Plant-based Medicinal Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Analytical Chemistry and Chromatography (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Pharmacology (282 citations), Clinical Biochemistry (54 citations), Oncology (105 citations), Pediatrics, Perinatology and Child Health (61 citations) and Biochemistry (23 citations). M Jurima has collaborated with scholars based in Canada. Frequent co-authors include T. Inaba, W. Kalow, W Kalow, D. Kadar, Masayuki Nakano and Bing Tang. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Canadian Journal of Physiology and Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.